ロード中...
BIM基因多态性与复治晚期非小细胞肺癌EGFR-TKI治疗疗效的关系
BACKGROUND AND OBJECTIVE: BIM gene is a member of the BCL-2 family, is involved in cell death. The aim of this study is to explore the relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitor (EG...
保存先:
| 出版年: | Zhongguo Fei Ai Za Zhi |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
中国肺癌杂志编辑部
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000640/ https://ncbi.nlm.nih.gov/pubmed/24345487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.12.03 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|